What to expect with FDA-approved ARESTIN®
In 2001, the Food and Drug Administration (FDA) approved ARESTIN® (minocycline HCl) Microspheres, 1 mg as an add-on therapy for scaling and root planing (SRP), to help reduce the depth of pockets in adults with periodontal (gum) disease. In the years since, over 1 million people have received ARESTIN® along with their periodontal procedure.
ARESTIN® is a locally administered antibiotic
Some people have allergies to certain antibiotics. ARESTIN® is a tetracycline antibiotic. Avoid tetracycline antibiotics if you are:
The use of tetracycline during tooth development can result in permanent discoloration of the teeth.
Common ARESTIN® side effects
The most frequently reported side effects in clinical studies were:
Who should not take ARESTIN®
Do not take ARESTIN® if you are allergic to minocycline or tetracyclines. Ask your dentist or pharmacist for a list of these drugs if you are not sure. Tell your dentist right away if you have any sign of allergic reaction, such as skin reactions or trouble breathing, or if you have an exaggerated sunburn reaction.
Does ARESTIN® have any side effects?
Patients treated with ARESTIN® may experience side effects. The most frequent non-dental adverse experiences reported in clinical research trials were headache, infection, flu syndrome, and pain. The most frequent dental treatment-emergent adverse experiences were inflammation of the gums, tooth disorder, tooth caries (cavities), and dental pain.
Learn how to work with your dental professionalContinue